Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Tezepelumab's trials
Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
Tezepelumab (Arm1&Arm2)
Ongoing
Not yet recruiting
Phase 3
Open NCT07302516 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record